Recent advances in analytical and sweat collection techniques provide new opportunities to identify non-invasive biomarkers for the study of skin inflammation and repair. This study aims to characterize the lipid mediator profile including oxygenated lipids, endocannabinoids and ceramides/sphingoid bases in sweat and identify differences in these profiles between sweat collected from non-lesional sites on the unflared volar forearm of subjects with and without atopic dermatitis (AD). Adapting routine procedures developed for plasma analysis, over 100 lipid mediators were profiled using liquid chromatography-tandem mass spectrometry and 58 lipid mediators were detected in sweat. Lipid mediator concentrations were not affected by sampling or storage conditions. Increases in concentrations of C30-C40 [NS] and [NdS] ceramides, and C18:1 sphingosine, were observed in the sweat of study participants with AD despite no differences being observed in transepidermal water loss between study groups, and this effect was strongest in men (p < 0.05, one way ANOVA with Tukey's post-hoc HSD). No differences in oxylipins and endocannabinoids were observed between study groups. Sweat mediator profiling may therefore provide a non-invasive diagnostic for AD prior to the presentation of clinical signs.
INTRODUCTION
Blood and urine have been extensively studied in the context of biomedical research and diagnostics. However, the collection of these biofluids can be physically and/or culturally invasive, affecting subject compliance. The use of non-invasive matrices such as hair, oral fluid, sweat and tears has improved subject compliance in pharmacokinetic studies (1) . Recently metabolomic analyses of sweat have begun for similar reasons (2) .
Sweat is a complex fluid excreted by apocrine and eccrine glands of the skin, reported to contain small molecules including electrolytes, urea, lactate, amino acids, metals and xenobiotics (2) . Sweat can be used for diagnostics when disease alters its composition, as has been demonstrated in cystic fibrosis where sweat chloride levels are elevated (3) . Sweat has also been used in forensic settings as a test matrix as most illicit drugs are excreted in sweat following administration by a variety of routes (4) .
Despite the potential diagnostic uses, there are few studies examining the metabolic profile of sweat due to a lack of uniform and reproducible sweat collection protocols that generate sweat in sufficient quantities for analytical sample processing (2, 5) . Reported sweat collection devices include simple occlusive or non-occlusive absorbent bandages applied to a body surface, bags that can encase a limb, and the Macroduct ® sweat collector (Wescor Inc., Logan, UT). In each case, sweat collection is preceded by stimulation of sweating by either physiological (exercise or thermal induction) or pharmacological (pilocarpine iontophoresis) means (2) . Of these the Macroduct ® sweat collector, which uses a concave disk and plastic capillary tubing to immediately collect and isolate sweat excreted to the skin surface following stimulation by pilocarpine, is perhaps the most suitable for metabolomics analysis since sweat collection is relatively fast (~30min/sample) and the design of the device prevents hydromeiosis and/or encapsulation of the skin surface (2, 6) .
While several proteomic analyses of sweat have been reported (7, 8) , only five attempts at metabolomic analyses of sweat have been described. High-resolution nuclear magnetic by guest, on www.jlr.org Downloaded from 4 resonance spectroscopy of sweat suggested the presence of several amino acids and lipidassociated groups (5, 9) . More recent mass spectrometry-based approaches confirmed the presence of amino acid-and lipid-derived molecules, while additionally showing the presence of carbohydrates and organic acids in sweat (10, 11) . Mass spectrometry-based metabolomics of sweat was also used to develop a screening tool for lung cancer (12) .
Despite the potential utility of sweat in diagnostic settings, it has rarely been used in the context of cutaneous research. To the best of our knowledge, only a single study exists that examines the composition of sweat in the context of cutaneous disease, a study that demonstrated no difference in the inflammation regulating lipid prostaglandin E2 (PGE2) levels in subjects with atopic dermatitis (AD), psoriasis or hyperhidrosis, relative to healthy controls (13) .
Bioactive lipids come in many forms and regulate a variety of processes including inflammation, cell growth and differentiation, and vascular homeostasis (14) . These mediators, which include oxygenated lipids ("oxylipins"), endocannabinoids and ceramides, are generally thought to be produced locally via biosynthetic pathways in response to extracellular stimuli and function similarly to local hormones or autacoids (14) . Additionally, ceramides play an important structural role in the epidermal barrier (15). While lipid mediators have been studied in cutaneous research, these studies have focused on a limited number of analytical targets and/or a single class of analytes (16) , barring the identification of mediator pathway cross-talk and limiting the scope of discovery in these studies.
Understanding the actions and interactions of lipid mediators has proven useful in other contexts (14) , and doing so in a non-invasive manner in the context of skin research could enhance our understanding of cutaneous biochemistry while ensuring minimal subject discomfort.
The present study aims to demonstrate the potential for sweat analysis to reflect biochemical impacts of skin diseases, by examining the impact of AD on the sweat profile of >100 lipid mediators from three chemical super-classes using targeted analyses. 
MATERIALS AND METHODS

Chemicals and reagents
Subjects
A total of 26 subjects (n = 13 in each group) were recruited to participate in a casecontrol study to examine the effects of AD on the sweat mediator lipidome between February 2015 and February 2016. Subjects were recruited from the University of California-Davis Dermatology Clinic and the Sacramento region. Inclusion criteria for the study included a diagnosis of AD by a dermatologist, or the absence of any inflammatory skin conditions for control subjects. Subjects on systemic immunosuppressive medications were excluded, and all subjects with AD were sampled while they were in the unflared state. Written informed consent was obtained from all subjects prior to participation, and all study protocols were approved by the Institutional Review Board of the University of California-Davis (Protocol #605131). Of the 26 subjects recruited, three were excluded. Two subjects with AD did not produce sweat upon stimulation, and one subject without AD had flared acne vulgaris at the time of sampling.
Therefore, the study proceeded with 11 subjects with and 12 subjects without AD. Group characteristics along with sampling and storage parameters are shown in Table 1 . followed by a distilled water-saturated sterile cotton gauze. Sweating was then stimulated sequentially on each forearm by pilocarpine iontophoresis using manufacturer-supplied pilocarpine gel disks attached to a power source containing two 9 V batteries. Pilocarpine iontophoresis was conducted for five minutes after which the forearm was wiped with a fresh distilled water-saturated sterile cotton gauze, and sweat was collected using the Macroduct 
UPLC-tandem mass spectrometry (UPLC-MS/MS) analysis was conducted using
modifications of previously published protocols (17, 18) . Briefly, three 10 µL aliquots of the reconstituted sample were sequentially injected onto an Acquity UPLC System (Waters), with one injection per lipid mediator profile analysis. Oxylipins and endocannabinoids were separated on a 2.1 x 150 mm, 1.7 µm BEH C18 column (Waters), while ceramides/sphingoid bases were separated on a 2.1 x 100 mm, 1.7 µm BEH C8 column (Waters) using the solvent gradients described in Supplemental Tables S1-S3 
Statistical Analysis
Statistical analysis generally followed previously published protocols (19) . All lipid mediator data were assessed by partial least squares discriminant analysis (PLS-DA), using disease state and/or subject gender, hand sampled, time of collection or storage time as the classifier. All statistical analyses were performed in the R-statistical environment (R Foundation for Statistical Computing, Vienna, Austria) using imDEV v1.42, a Microsoft Excel (Microsoft Corporation, Redmond, WA) Add-In (20) .
Prior to PLS-DA, data were curated such that analytes with < 70% completeness of data were removed from consideration. Curated data were screened for outliers using the Grubb's test (21) , and missing data were imputed by a two-component probabilistic principle components analysis with univariate scaling (22) . Additionally ceramide and sphingoid base data was not collected for four male subjects, two with and two without AD. To allow the unbiased use of these subjects' oxylipin and endocannabinoid data in PLS-DA analyses, this missing data was interpolated as the gender-independent mean of the remaining subject's data in each AD group.
The interpolated ceramide results were not used for the mean comparisons described below.
Following normalization of data according to the procedures of Box and Cox (23), PLS-DA was conducted using the orthogonal scores algorithm with univariate scaling and leave-one-out crossvalidation. Variables were clustered by Spearman correlation coefficients using the Minkowski distance and Ward agglomeration.
All means comparisons were performed using MetaboAnalyst 3.0 (24). For subjects with and without AD classified by gender, mean differences were tested by false discovery rate corrected one-way ANOVA with Tukey's post-hoc HSD. Mean differences in sampling or storage were tested for AD groups separately using Student's t-test with false discovery rate correction. Additionally, three subjects with and three subjects without AD were randomly selected and mean sweat lipid mediator concentrations from the right and left volar forearms were 
RESULTS
Lipid mediators in eccrine sweat
A total of 58 lipid mediators were quantified in the sweat of subjects with and without ceramides, dihydroceramides and C18:1 sphingosine as the dominant discriminating factors ( Figure 2B) . The PLS-DA also highlighted a gender-dependent effect, with mediator profiles increasing more in men than women, and where men with and without AD are better separated than women (Figure 2A) . Comparing the relative fold differences in ceramides and sphingosine between subjects with and without AD when separated by gender highlights this observation (Figure 2C-D) . Specifically, men with AD have ~2-6 fold higher ceramides and sphingosine compared to men without AD whereas women with AD only have ~1-1.5 fold higher ceramides and sphingosine compared to women without AD. Transepidermal water loss, an indicator of skin barrier status, was not different between subjects with and without AD ( Table 1) .
Impact of sampling and storage on sweat lipid mediator profile
Lipid mediators discriminating between subjects with and without AD (i.e. ceramides and sphingoid bases) were unaffected by the sampling time, sampling site, or storage conditions used in this study. In particular, no differences were observed within each subject group (i.e. subjects with and without AD) when the data were grouped by time of collection (09:00 -14:00 or 14:00 Table S5 ), however these changes were excluded after false discovery rate correction for multiple comparisons (q = 0.05).
DISCUSSION
Sweat's physiological role in heat dissipation is well known, as is its basic chemical composition, i.e. water and salt. However, sweat also contains a wide array of other small molecules that can be influenced by disease states and environmental exposures, thus offering access to a potentially valuable and non-invasive biological sample. Lipid biochemistry produces a wide variety of bioactive molecules that have important regulatory roles in inflammation and were not observed between the groups (p > 0.05). PGD2 was not detected. Given that the study subjects with AD were sampled in an unflared state and samples were obtained from non-lesional skin, these findings support the pathognomonic association of PGE2 and AEA with the inflammatory sequela of AD, rather than its pathogenesis.
There would therefore appear to be agreement between published cutaneous lipid mediator changes and those observed in sweat in the context of AD, particularly with respect to ceramides and sphingoid bases. It is interesting that these differences in ceramides and sphingoid bases usually correlated with epidermal barrier dysregulation were observed in non-lesional skin from subjects with unflared AD, given that an impaired epidermal barrier in AD is usually associated with active lesions or non-lesional skin adjacent to active lesions (47) . Therefore, the sweat mediator lipidome appears to indicate a sustained biochemical dysregulation in subjects with AD and may provide an opportunity for pre-clinical diagnostics. This potential utility warrants further studies to assess the specificity and sensitivity of the observed changes, by ceramides, and sphingoid bases in eccrine sweat collected from the volar forearm. Additionally, this study demonstrates an apparently robust and novel non-invasive tool that could be used to support cutaneous research. Future studies will investigate the ability of sweat to report on the biochemical milieu of skin inflammation, directly compare the impact of physiologic versus pharmacologic sweat stimulation, and assess the variance in sweat composition associated with collection from other anatomical regions as we begin to scratch the surface of this novel and exciting addition to cutaneous research.
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